BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
53.18
-0.80 (-1.48%)
At close: Apr 24, 2026, 4:00 PM EDT
54.24
+1.06 (1.99%)
After-hours: Apr 24, 2026, 5:17 PM EDT
BioMarin Pharmaceutical Analyst Ratings
Total Analysts
18
Consensus Rating
Buy
Price Target
$88.22
Upside
+65.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $97 → $85 | Strong Buy | Maintains | $97 → $85 | +59.83% | Mar 11, 2026 |
| Barclays | Barclays | Buy Maintains $80 → $105 | Buy | Maintains | $80 → $105 | +97.44% | Mar 4, 2026 |
| Freedom Broker | Freedom Broker | Strong Buy Maintains $100 → $105 | Strong Buy | Maintains | $100 → $105 | +97.44% | Mar 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $55 | Hold | Reiterates | $55 | +3.42% | Mar 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $98 → $104 | Strong Buy | Maintains | $98 → $104 | +95.56% | Feb 26, 2026 |
| Bernstein | Bernstein | Buy Maintains $90 → $94 | Buy | Maintains | $90 → $94 | +76.76% | Feb 25, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $106 → $86 | Strong Buy | Maintains | $106 → $86 | +61.71% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $60 → $55 | Hold | Maintains | $60 → $55 | +3.42% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $98 → $95 | Buy | Maintains | $98 → $95 | +78.64% | Feb 24, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $70 → $75 | Buy | Maintains | $70 → $75 | +41.03% | Feb 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $122 → $84 | Buy | Maintains | $122 → $84 | +57.95% | Feb 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold → Strong Buy Upgrades $84 → $98 | Hold → Strong Buy | Upgrades | $84 → $98 | +84.28% | Jan 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $80 → $100 | Strong Buy | Maintains | $80 → $100 | +88.04% | Dec 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $55 → $60 | Hold | Maintains | $55 → $60 | +12.82% | Dec 22, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $82 → $60 | Buy → Hold | Downgrades | $82 → $60 | +12.82% | Dec 3, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $73 → $61 | Strong Buy → Hold | Downgrades | $73 → $61 | +14.70% | Nov 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.